SU
₹1,099.40
-10.10(-0.91%)
SUDEEPPHRM₹1,099.40-0.91%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-endThis is the flow into the whole Healthcare sector, not into SUDEEPPHRM. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsSUDEEPPHRM exposure summary
In its latest segment disclosure (Jun 2026), Pharmaceutical, food and nutrition was the largest segment at 68.5% of segment revenue, followed by Speciality Ingredients at 31.5%. Sudeep Pharma Limited is a constituent of 1 index.
| Index memberships | 1 |
|---|---|
| Largest segment | Pharmaceutical, food and nutrition · 68.5% |